Loading the company…
Loading the company…
㈜우성에프앤티
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-11-02 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Seoul, founded in 2003. Industry: Food & Consumer Goods. Revenue for 2025 was ₩27.7bn. It has 15 employees enrolled in the National Pension Service (as of Aug 2026). It is externally audited; the latest audit opinion is “Unqualified”.
Loading…
Latest filing 2020-06-30 · latest registration 2021-02-26 · newest first
본 발명은 항균 마스크 제조용 원단(50) 및 이를 이용한 일체형 항균 마스크(100)에 관한 것으로, 구체적으로는 유통되는 공기 중 및 마스크에 부착된 병원체를 살균 또는 멸균함으로써 위생적으로 사용이 가능하고, 또한, 내부의 습도조절기능에 의해 장시간 착용시 발생할 수 있는 피부 트러블 및 세균 증식을 방지하여 2차 감염을 예방하는 항균 마스크 제조용 원단(50) 및 이를 이용한 일체형 항균 마스크(100)에 관한 것이다.
KIPO KIPRIS · checked 2026-10-15 · newest filings first · right: registration date (filing date if not yet registered) · 1 of 1 · titles and abstracts are in Korean as filed · click a row for details ▾
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2024 | 2025 |
|---|---|---|
| Revenue | 26.4 | 27.7 |
| Cost of sales | 24.5 | 25.4 |
| Gross profit (loss) | 1.9 | 2.2 |
| Selling, general and administrative expenses | 1.1 | 1.6 |
| Operating income (loss) | 0.8 | 0.6 |
| Non-operating income | 0.1 | 0.1 |
| Other gains | 0.1 | 0.0 |
| Finance income | 0.0 | 0.0 |
| Other | — | 0.1 |
| Non-operating expenses | 0.6 | 0.5 |
| Other losses | 0.1 | 0.0 |
| Finance costs | 0.3 | 0.2 |
| Other | 0.3 | 0.3 |
| Profit (loss) before tax | 0.2 | 0.2 |
| Income tax expense | 0.1 | 0.1 |
| Net income (loss) | 0.1 | 0.1 |
Revenue ₩27.7bn, up 4.7% YoY.
Operating margin 2.1% (prior 2.9%).
Net income ₩0.1bn.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.
Headlines and links to public articles only · not checked by us (original ↗) · articles are in Korean — English headlines are our translation; where none is shown, “Read in English ›” opens a machine translation · “Broker view” is a forecast, not reported results · checked 2026-11-06